OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 60 filers reported holding OBALON THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | -57.1% | 5,000 | 0.0% | 0.00% | – |
| Q1 2019 | $7,000 | -30.0% | 5,000 | 0.0% | 0.00% | – |
| Q4 2018 | $10,000 | -28.6% | 5,000 | 0.0% | 0.00% | – |
| Q3 2018 | $14,000 | +16.7% | 5,000 | -11.2% | 0.00% | – |
| Q2 2018 | $12,000 | -42.9% | 5,633 | -10.1% | 0.00% | – |
| Q1 2018 | $21,000 | +162.5% | 6,268 | +453.7% | 0.00% | – |
| Q4 2017 | $8,000 | +700.0% | 1,132 | +1117.2% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 93 | -30.6% | 0.00% | – |
| Q1 2017 | $1,000 | -97.7% | 134 | -97.2% | 0.00% | – |
| Q4 2016 | $43,000 | – | 4,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|